Which longevity peptides work best for lifespan extension?
No peptide has been shown to make people live longer, and none is being tested for it. The mitochondrial peptides have the most believable science and no human ageing trials; epitalon's life-extension claims are decades old and never independently confirmed; growth-hormone peptides may work against longevity biology rather than for it. The things with real evidence for a longer life — controlling blood pressure and cholesterol, not smoking, exercising — are not peptides.
No peptide has been shown to extend human lifespan, and none has a trial designed to test it. Ranked on how close the evidence comes: SS-31 (elamipretide) and MOTS-c have the best mechanistic case — mitochondrial peptides with rodent data on function and, for MOTS-c, healthspan markers — and no human ageing trial; humanin has a striking association with longevity in centenarian cohorts and no intervention trial; epitalon has decades-old Russian reports of extended lifespan in animals and in small elderly cohorts, never independently replicated; tesamorelin and the growth-hormone secretagogues rank low because the axis they raise is, in most ageing biology, associated with shorter life when higher, not longer; BPC-157, TB-500 and the rest have no lifespan data of any kind. The interventions with the strongest human evidence bearing on lifespan — blood-pressure and lipid control, not smoking, exercise — are not peptides, and the compounds with the best animal lifespan data in independent programmes are small molecules such as rapamycin, not peptides.
- Lifespan is the one outcome no peptide has been tested on in humans; every claim is animal data, a cohort association, or an unreplicated report.
- The mitochondrial peptides have the most credible biology and are, respectively, in trials for rare diseases (SS-31) and untested in people (MOTS-c).
- Epitalon's lifespan claims are the oldest and the least replicated; a claim that has waited thirty years for independent confirmation is a claim without it.
- Growth-hormone peptides rank low for lifespan specifically: lower GH/IGF-1 signalling is associated with longer life across species, which cuts against the mechanism they sell.
- The best animal lifespan data in independent, replicated programmes belong to small molecules and to caloric restriction, not to any peptide.
Peptides ranked on lifespan evidence
Ranked on: how close the evidence comes to a lifespan claim: independent, replicated animal lifespan data ranks above single-group reports; a human development programme ranks above none; a mechanism that fits ageing biology ranks above one that contradicts it. Human lifespan evidence does not exist for any item.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | SS-31 (elamipretide) | Best biology; in human trials for rare diseases, not ageing | GRADE CEarly |
| 2 | MOTS-c | Healthspan markers in mice; no human trial | GRADE DInsufficient or unsafe |
| 3 | Humanin | Associated with longevity in cohorts; never given as an intervention | GRADE DInsufficient or unsafe |
| 4 | Epitalon | Old lifespan reports, never independently replicated | GRADE DInsufficient or unsafe |
| 5 | Tesamorelin, sermorelin, CJC-1295, ipamorelin | Raise the axis that longevity biology says to lower | GRADE DInsufficient or unsafe |
| 6 | BPC-157, TB-500, AOD-9604, GHK-Cu, DSIP, semax, selank, melanotan II | No lifespan data of any kind | GRADE DInsufficient or unsafe |
- 01
SS-31 (elamipretide)
GRADE CEarlyBest biology; in human trials for rare diseases, not ageingA mitochondrial-membrane peptide with rodent data on muscle, heart and kidney function in aged animals and a genuine clinical development programme in Barth syndrome and mitochondrial myopathy, with mixed results. The closest thing on this list to a peptide being tested properly — for something other than lifespan, in patients rather than the ageing population. Not sold lawfully as an anti-ageing product.
A mitochondrial-derived peptide that improved exercise capacity, insulin sensitivity and some ageing markers in rodents, with a plausible mechanism. No human trial of any kind. Ranked above epitalon because the animal work is recent and from more than one laboratory; ranked D because there is nothing in people.
- 03
Humanin
GRADE DInsufficient or unsafeAssociated with longevity in cohorts; never given as an interventionHigher circulating levels of this mitochondrial-derived peptide track with longevity in centenarian offspring and decline with age. That is an association, not an effect; no intervention trial exists and no product is lawfully available. Interesting biology, no evidence that giving it does anything.
Russian reports from the 1990s and 2000s of extended lifespan in rodents and reduced mortality in small elderly cohorts, from essentially one research tradition, with no independent replication in thirty years. The most explicit lifespan claim on this list and, for that reason, the one whose absence of confirmation matters most.
- 05
Tesamorelin, sermorelin, CJC-1295, ipamorelin
GRADE DInsufficient or unsafeRaise the axis that longevity biology says to lowerGrowth-hormone-axis peptides raise GH and IGF-1. Reduced GH/IGF-1 signalling extends lifespan in worms, flies and mice, and humans with growth-hormone-receptor deficiency show reduced cancer and diabetes. Tesamorelin is approved and useful for its indication; as lifespan interventions, this group has a mechanism pointing the wrong way. Grade D for lifespan specifically; tesamorelin remains A on the site for its approved evidence.
- 06
BPC-157, TB-500, AOD-9604, GHK-Cu, DSIP, semax, selank, melanotan II
GRADE DInsufficient or unsafeNo lifespan data of any kindRepair, sleep, cognition, tanning and fat-loss claims respectively — none of them accompanied by lifespan data in any species. They are on this page because they are sold alongside the lifespan claim, not because any evidence connects them to it.
Against the interventions that have evidence
What lifespan evidence looks like, and where peptides sit
| Intervention | Best evidence for a longer life | Type | Grade on this site |
|---|---|---|---|
| Blood-pressure control to target | Randomised outcome trials: fewer deaths | Human, hard outcome | A |
| LDL / ApoB lowering | Meta-analysis of 26 randomised trials: lower all-cause mortality | Human, hard outcome | A |
| Not smoking | Cohorts: roughly ten years of life expectancy | Human, observational, very large | A |
| Cardiorespiratory fitness | Cohorts: strongest single predictor of mortality | Human, observational | A |
| Rapamycin | Extended lifespan in mice in an independent, replicated programme | Animal, replicated | See therapy page |
| Caloric restriction | Extended lifespan across species; human trial on markers | Animal, replicated; human surrogate | See protocols |
| SS-31 | Function in aged rodents; human trials in rare diseases | Animal; human non-ageing | C |
| MOTS-c | Healthspan markers in mice | Animal | D |
| Epitalon | Unreplicated lifespan reports | Animal and small human, single tradition | D |
| GH-axis peptides | Mechanism contradicts longevity biology | — | D for lifespan |
Frequently asked questions
Which peptides extend lifespan?
None has been shown to extend human lifespan, and none is in a trial designed to test it. Ranked on how close the evidence comes: SS-31 has credible mitochondrial biology and human trials for rare diseases; MOTS-c has rodent healthspan data and no human trial; humanin is associated with longevity in cohorts but has never been given as an intervention; epitalon has decades-old, unreplicated lifespan reports; growth-hormone peptides raise an axis that longevity biology says to lower; the rest have no lifespan data of any kind.
Does epitalon extend life?
The claim comes from Russian reports of the 1990s and 2000s — extended lifespan in rodents and reduced mortality in small elderly cohorts — from essentially one research tradition, with no independent replication in thirty years. A lifespan claim that has waited that long for confirmation is a claim without it.
Why do growth-hormone peptides rank low for lifespan?
Because they raise growth hormone and IGF-1, and reduced signalling on that axis extends lifespan in worms, flies and mice, while humans with growth-hormone-receptor deficiency show less cancer and diabetes. The mechanism they sell points the wrong way for longevity. Tesamorelin remains an approved, useful drug for its indication; that is a different question.
Is MOTS-c the most promising longevity peptide?
It has the most interesting recent biology — a mitochondrial-derived peptide that improved exercise capacity, insulin sensitivity and ageing markers in rodents, from more than one laboratory — and no human trial of any kind. Promising is the right word; evidence is not. It is sold as an injectable with unverified purity and no lawful compounding route in the US.
What has actual evidence for a longer life?
Blood-pressure control and LDL lowering (randomised trials with fewer deaths), not smoking (about ten years of life expectancy in cohorts), and cardiorespiratory fitness (the strongest single predictor of mortality). Among compounds, rapamycin has replicated animal lifespan data in an independent programme and caloric restriction extends lifespan across species. None of these is a peptide.
Is any peptide in a human longevity trial?
No. SS-31 is in trials for rare mitochondrial diseases, which is the closest any peptide comes to a proper development programme. The human ageing trials that exist — for metformin, rapamycin, NAD precursors and others — are small, early and measure surrogates, and none of them involves a peptide sold for longevity.
Keep reading
- What are the safest and best longevity peptides?
The same compounds ranked on safety and regulatory status.
- Rapamycin
The compound with the best replicated animal lifespan data — not a peptide.
- Which daily habits offer the best longevity benefits?
The interventions with human evidence for living longer.
- How we grade evidence
Why animal lifespan data never earns an A.
More in Peptides
- Peptides and therapies commonly used to extend lifespan.
Peptides and adjacent therapies marketed for lifespan extension ranked on human evidence: GLP-1 agonist peptides with outcome trials, growth-hormone-releasing peptides, BPC-157 and other repair peptides, NAD+ infusion therapy, and 'longevity peptide stacks' — with what is actually proven versus what is commonly used.
- Which longevity peptides are best for energy and recovery?
BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin, sermorelin, tesamorelin — ranked on human trials for energy and recovery. Most have none. Here is what actually exists.
- What are the safest and best longevity peptides?
Longevity peptides ranked on safety and human evidence together: tesamorelin, PT-141, sermorelin, GHK-Cu, semax and selank, DSIP, then the unregulated injectables — BPC-157, TB-500, MOTS-c, CJC-1295/ipamorelin, epitalon, AOD-9604, melanotan II — with the regulatory status of each.
- Best longevity peptides for anti-aging and cellular repair.
Longevity peptides ranked on their anti-ageing and cellular-repair claims: what each is supposed to repair, what the human evidence shows, and why GHK-Cu on skin outranks every injectable — tesamorelin, BPC-157, TB-500, epitalon, MOTS-c, thymosin alpha-1 and more.
- Best longevity peptides for beginners to start with.
Longevity peptides for beginners, ranked on what a first peptide should be — lawful, prescribed, human-studied, low-risk: topical GHK-Cu, then approved peptides via a prescriber, then the grey-market injectables that beginners are usually sold first and should try last, if at all.
- What are the top doctor-recommended longevity peptides?
Doctor-recommended longevity peptides ranked by what the recommendation rests on: guideline-backed prescribing (tesamorelin, bremelanotide), evidence-informed off-label use (sermorelin), and the clinic-menu peptides — BPC-157, TB-500, CJC-1295/ipamorelin — that are recommended commercially and cannot be lawfully compounded.